These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17092465)

  • 1. Intravenous immunoglobulin for Guillain-Barré syndrome: how effective?
    Tasdemir HA; Dilber C; Kanber Y; Uysal S
    J Child Neurol; 2006 Nov; 21(11):972-4. PubMed ID: 17092465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of IV Immunoglobulin in Indian Children With Guillain-Barré Syndrome.
    Kalita J; Kumar M; Misra UK
    Pediatr Crit Care Med; 2019 Jul; 20(7):652-659. PubMed ID: 30985608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Raphaël JC; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2006 Jan; (1):CD002063. PubMed ID: 16437439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2010 Jun; (6):CD002063. PubMed ID: 20556755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Raphaël JC; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2001; (2):CD002063. PubMed ID: 11406030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Raphaël JC; Swan AV; Doorn PA
    Cochrane Database Syst Rev; 2004; (1):CD002063. PubMed ID: 14973982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome: critical reassessment of effectiveness and cost-efficiency.
    Oczko-Walker M; Manousakis G; Wang S; Malter JS; Waclawik AJ
    J Clin Neuromuscul Dis; 2010 Dec; 12(2):55-61. PubMed ID: 21386771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, electrophysiological findings and evaluation of prognosis of patients with Guillain-Barré syndrome.
    Kılıç B; Güngör S; Özgör B
    Turk J Pediatr; 2019; 61(2):200-208. PubMed ID: 32077646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Treatment Strategy for Severe Guillain-Barré Syndrome: Zipper Method.
    Kesici S; Tanyıldız M; Yetimakman F; Bayrakci B
    J Child Neurol; 2019 Apr; 34(5):277-283. PubMed ID: 30696330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of immunoglobulin in severe childhood Guillain-Barré syndrome.
    Ortiz-Corredor F; Peña-Preciado M
    Acta Neurol Scand; 2007 Apr; 115(4):289-93. PubMed ID: 17376129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intravenous immunoglobulin in children with Guillain-Barré syndrome].
    Bruck I; Antoniuk SA; Cat R; Spessatto A; Halick SM; Bruyn LR; Rodrigues M; Scola RH; Werneck LC
    Arq Neuropsiquiatr; 2000 Dec; 58(4):1081-91. PubMed ID: 11105076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin as therapy for pediatric Guillain-Barré syndrome.
    Abd-Allah SA; Jansen PW; Ashwal S; Perkin RM
    J Child Neurol; 1997 Sep; 12(6):376-80. PubMed ID: 9309521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmapheresis treatment in Guillain-Barré syndrome: potential benefit over intravenous immunoglobulin.
    Buzzigoli SB; Genovesi M; Lambelet P; Logi C; Raffaelli S; Cattano D
    Anaesth Intensive Care; 2010 Mar; 38(2):387-9. PubMed ID: 20369779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guillain-Barré syndrome with central nervous system symptoms. Report of two cases].
    Łabuz-Roszak B; Pierzchała K; Kapustecki J; Biernawska J; Mańka I; Kumor K
    Neurol Neurochir Pol; 2004; 38(3):221-6. PubMed ID: 15354236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome.
    Ansar V; Valadi N
    Prim Care; 2015 Jun; 42(2):189-93. PubMed ID: 25979580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma exchange for Guillain-Barré syndrome.
    Raphaël JC; Chevret S; Hughes RA; Annane D
    Cochrane Database Syst Rev; 2001; (2):CD001798. PubMed ID: 11406009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma exchange for Guillain-Barré syndrome.
    Raphaël JC; Chevret S; Hughes RA; Annane D
    Cochrane Database Syst Rev; 2002; (2):CD001798. PubMed ID: 12076424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guillain-Barré syndrome in children treated with intravenous immunoglobulin].
    Andersen UM
    Ugeskr Laeger; 1993 Oct; 155(42):3392-4. PubMed ID: 8259633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guillain-Barre syndrome in children in 2009-2014 years].
    Stasiak K; Wesołowska E; Kroczka S
    Przegl Lek; 2016; 73(3):167-9. PubMed ID: 27349047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year prospective study (clinical spectrum) of childhood Guillain-Barré syndrome in the Arabian peninsula: comparison of outcome in patients in the pre- and post-intravenous immunoglobulin eras.
    Koul R; Chacko A; Ahmed R; Varghese T; Javed H; Al-Lamki Z
    J Child Neurol; 2003 Nov; 18(11):767-71. PubMed ID: 14696904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.